ICU MEDICAL INC/DE Cash And Cash Equivalents At Carrying Value

Quick Answer

ICU MEDICAL INC/DE reported Cash And Cash Equivalents At Carrying Value of $208.78 million for the year ending 2022.

  • ICU MEDICAL INC/DE showed a decrease of -62.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 27, 2023.
  • XBRL data for this metric is available from 2008 to 2022 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2009: $62.59 million | Q3 2009: $53.26 million | Q1 2010: $42.90 million | Q2 2010: $57.60 million | Q3 2010: $65.67 million | Q1 2011: $71.11 million | Q2 2011: $87.37 million | Q3 2011: $122.10 million | Q1 2012: $122.10 million | Q2 2012: $121.56 million | Q3 2012: $127.52 million | Q1 2013: $154.63 million | Q2 2013: $170.59 million | Q3 2013: $188.03 million | Q1 2014: $227.62 million | Q2 2014: $252.24 million | Q3 2014: $252.24 million | Q1 2015: $308.53 million | Q2 2015: $331.09 million | Q3 2015: $355.37 million | Q1 2016: $347.37 million | Q2 2016: $372.90 million | Q3 2016: $322.96 million | Q1 2017: $201.86 million | Q2 2017: $240.92 million | Q3 2017: $300.61 million | Q1 2018: $318.82 million | Q2 2018: $309.10 million | Q3 2018: $318.82 million | Q1 2019: $296.04 million | Q2 2019: $291.87 million | Q3 2019: $315.95 million | Q1 2020: $419.56 million | Q2 2020: $446.13 million | Q3 2020: $350.99 million | Q1 2021: $424.25 million | Q2 2021: $462.04 million | Q3 2021: $519.49 million.
  • Over the full 15 years of available data (2008 to 2022), ICU MEDICAL INC/DE's Cash And Cash Equivalents At Carrying Value has grown by 274.9%.
  • Historical annual values: Fiscal year 2022: $208.78 million | Fiscal year 2021: $552.83 million | Fiscal year 2020: $396.10 million | Fiscal year 2019: $268.67 million | Fiscal year 2018: $344.78 million | Fiscal year 2017: $290.07 million | Fiscal year 2016: $445.08 million | Fiscal year 2015: $336.16 million | Fiscal year 2014: $275.81 million | Fiscal year 2013: $226.02 million | Fiscal year 2012: $146.90 million | Fiscal year 2011: $99.59 million | Fiscal year 2010: $78.85 million | Fiscal year 2009: $51.25 million | Fiscal year 2008: $55.70 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: